APA (7th ed.) Citation

J, R., SS, A., E, S. D., LP, H., CN, H., WS, J., . . . MR, P. (2023). Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD. Circulation, 148(24), 1919. https://doi.org/10.1161/CIRCULATIONAHA.122.063806

Chicago Style (17th ed.) Citation

J, Rymer, et al. "Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD." Circulation 148, no. 24 (2023): 1919. https://doi.org/10.1161/CIRCULATIONAHA.122.063806.

MLA (9th ed.) Citation

J, Rymer, et al. "Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD." Circulation, vol. 148, no. 24, 2023, p. 1919, https://doi.org/10.1161/CIRCULATIONAHA.122.063806.